Abstract:Effective drug discovery and molecular optimization procedures depend heavily on a comprehensive understanding of the reciprocal drug‐membrane interactions. This review explores recent developments in microfluidic lipid biomimetic models for screening these interactions. A synopsis of lipid‐based drug screening models is provided, along with a deeper analysis of the most promising microfluidic methods for their production and applications on drug screening. Developing new drugs is a complex, time‐consuming, and expensive process, essential to identify potential pharmacokinetic issues in the early stages to avoid investment in nonpromising candidates. Nearly half of all drug targets and key drug‐metabolizing enzymes are found in intracellular environments, compartmentalized by semipermeable barriers, the cell membranes. Inspired by their lipidic bilayer structure, lipid‐based biomimetic platforms are being developed to understand the biochemical and biophysical processes at the cellular membrane level. Considering the pharmaceutical industry's demands for efficient in vitro high throughput screening tools, microfluidic technology emerges as a promising solution to address challenges in lipid biomimetic models for screening applications. This involves the transformation of commonly used lipid‐based biomimetic models, like supported lipid bilayers and lipid vesicles, to miniaturized approachs and their evolution into a new generation of bilayer models. These include pore‐suspended and free‐standing lipid bilayers, black lipid membranes, and droplet interface bilayers. This review provides an overview of both generations of lipid biomimetic models used in drug‐membrane screening applications. Moreover, it delves into the intricacies of their production through microfluidic approaches and examines their screening applications in drug‐membrane interaction. The review concludes with a critical analysis of potential future directions in this rapidly evolving field.

Polymer membrane and cell models for drug discovery.

PC Technology Improving the Hemocompatibility of Polymer Membranes Developed for Biomedical Application

Cell models and drug discovery for mitochondrial diseases

Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development

Lipid Microfluidic Biomimetic Models for Drug Screening: A Comprehensive Review

Complex in Vitro Model: A Transformative Model in Drug Development and Precision Medicine

Recent advances in cell membrane-coated technology for drug discovery from natural products

PPO/PEO Modified Hollow Fiber Membranes Improved Sensitivity of 3D Cultured Hepatocytes to Drug Toxicity Via Suppressing Drug Adsorption on Membranes.

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Regulation Of Epithelial Cell Morphology And Functions Approaching To More In Vivo-Like By Modifying Polyethylene Glycol On Polysulfone Membranes

Development of biomimetic Phospholipid membrane chromatography for drug discovery: A comprehensive review

Back to the Future: Can Physical Models of Passive Membrane Permeability Help Reduce Drug Candidate Attrition and Move Us Beyond QSPR?

Drugging Membrane Protein Interactions

Liposomes as biomembrane models: Biophysical techniques for drug-membrane interaction studies

Application of Mechanistic Modelling in Membrane and Fiber Chromatography for Purification of Biotherapeutics – A Review

Biomembrane surfaces as models for polymer design: the potential for haemocompatibility

Polymersomes in Drug Delivery─From Experiment to Computational Modeling

Membranes for Modelling Cardiac Tissue Stiffness In Vitro Based on Poly(trimethylene carbonate) and Poly(ethylene glycol) Polymers

Polymersome Membrane Engineering with Active Targeting or Controlled Permeability for Responsive Drug Delivery

Advancements in Engineering Planar Model Cell Membranes: Current Techniques, Applications, and Future Perspectives